drug

ferric carboxymaltose injection

1 story · latest Aug 6, 2026

Status: FDA approved Jul 2013 · NDA203565
Brands: Ferric Carboxymaltose, Injectafer

Relationships

Developed by Daiichi Sankyo

Timeline

Viatris raises 2026 guidance, reports FDA approvals and Tyrvaya sale in Q2 update

Aug 6Quarterly updatevarenicline Viatris Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.